These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 23192764)
1. High expression of cancer stem cell markers in cholangiolocellular carcinoma. Iwahashi S; Utsunomiya T; Shimada M; Saito Y; Morine Y; Imura S; Ikemoto T; Mori H; Hanaoka J; Bando Y Surg Today; 2013 Jun; 43(6):654-60. PubMed ID: 23192764 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma. Liu J; Brown RE Int J Clin Exp Pathol; 2010 Oct; 3(8):755-62. PubMed ID: 21151388 [TBL] [Abstract][Full Text] [Related]
3. Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: trials, tribulations and a cautionary note. James MI; Howells LM; Karmokar A; Higgins JA; Greaves P; Cai H; Dennison A; Metcalfe M; Garcea G; Lloyd DM; Berry DP; Steward WP; Brown K PLoS One; 2015; 10(2):e0117776. PubMed ID: 25658706 [TBL] [Abstract][Full Text] [Related]
4. Lessons from common markers of tumor-initiating cells in solid cancers. Gires O Cell Mol Life Sci; 2011 Dec; 68(24):4009-22. PubMed ID: 21786143 [TBL] [Abstract][Full Text] [Related]
5. Cancer stem cells in lung cancer: Evidence and controversies. Alamgeer M; Peacock CD; Matsui W; Ganju V; Watkins DN Respirology; 2013 Jul; 18(5):757-64. PubMed ID: 23586700 [TBL] [Abstract][Full Text] [Related]
6. Murine hepatoblast-derived liver tumors resembling human combined hepatocellular-cholangiocarcinoma with stem cell features. Cai X; Li H; Kaplan DE Cell Biosci; 2020; 10():38. PubMed ID: 32190288 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma. Sasaki M; Sato H; Kakuda Y; Sato Y; Choi JH; Nakanuma Y Liver Int; 2015 Mar; 35(3):1024-35. PubMed ID: 24712771 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic significance of combined hepatocellular-cholangiocarcinoma with stem cell subtype components with reference to the expression of putative stem cell markers. Ikeda H; Harada K; Sato Y; Sasaki M; Yoneda N; Kitamura S; Sudo Y; Ooi A; Nakanuma Y Am J Clin Pathol; 2013 Sep; 140(3):329-40. PubMed ID: 23955451 [TBL] [Abstract][Full Text] [Related]
9. Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis. Thanan R; Pairojkul C; Pinlaor S; Khuntikeo N; Wongkham C; Sripa B; Ma N; Vaeteewoottacharn K; Furukawa A; Kobayashi H; Hiraku Y; Oikawa S; Kawanishi S; Yongvanit P; Murata M Free Radic Biol Med; 2013 Dec; 65():1464-1472. PubMed ID: 23917144 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification. Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123 [TBL] [Abstract][Full Text] [Related]
11. Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma. Kim SH; Park YN; Lim JH; Choi GH; Choi JS; Kim KS Eur J Surg Oncol; 2014 Aug; 40(8):976-81. PubMed ID: 24909336 [TBL] [Abstract][Full Text] [Related]
18. Clinical significances of cancer stem cells markers in patients with intrahepatic cholangiocarcinoma who underwent hepatectomy. Nanashima A; Hatachi G; Tsuchiya T; Matsumoto H; Arai J; Abo T; Murakami G; Tominaga T; Takagi K; Nagayasu T Anticancer Res; 2013 May; 33(5):2107-14. PubMed ID: 23645762 [TBL] [Abstract][Full Text] [Related]
19. 3D Silk Fibroin-Gelatin/Hyaluronic Acid/Heparan Sulfate Scaffold Enhances Expression of Stemness and EMT Markers in Cholangiocarcinoma. Buhome O; Wongwattanakul M; Daduang J; Limpaiboon T In Vivo; 2022; 36(3):1155-1167. PubMed ID: 35478144 [TBL] [Abstract][Full Text] [Related]
20. Long Non-Coding RNAs in Biliary Tract Cancer-An Up-to-Date Review. Bekric D; Neureiter D; Ritter M; Jakab M; Gaisberger M; Pichler M; Kiesslich T; Mayr C J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32331331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]